Clinical Trial Update: Liposomal Annamycin in Children and Young Adults With Refractory or Relapsed ALL or AML [Phase 1]

View source ↗

Summary

A Phase 1 trial of liposomal annamycin in children and young adults with refractory or relapsed acute lymphoblastic leukemia or acute myeloid leukemia was termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• Liposomal Annamycin (annamycin liposome)

Snippet

Sponsor: Callisto Pharmaceuticals | Conditions: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia | Phase 1 | Status: TERMINATED